Not Yet Recruiting
[18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC)
NCT07723651
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
- University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States
- University of Texas MD Anderson Cancer Center Houston, Texas, United States